| Name | Title | Contact Details |
|---|---|---|
Alexandra Izquierdo |
Director of People, Global | Profile |
Glenn Sward |
Vice President, Talent Acquisition and Development | Profile |
Barry Lederman |
CFO - Chief Financial Officer - Private Equity | Profile |
Karin Keller |
Associate Director, Head of Method Development and Validation | Profile |
Michael Nawa |
Director, Global Digital Marketing | Profile |
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
At Gynesonics our mission is to design and develop new and advanced technologies for improving women`s health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids. We are initiating a pivotal IDE trial in the United States to verify the safety and efficacy of the Sonata system, in preserving the uterus while treating those fibroids associated with abnormal uterine bleeding that are difficult to treat with existing technology and surgical techniques. We are committed to providing women with a safe and effective incision-free alternative to the invasive surgical techniques of hysterectomy or myomectomy for their severe menstrual symptoms associated with fibroids.
Eden Health eliminates the hassle of healthcare for employers and their employees. We`re a new kind of doctor`s office that combines a private primary care practice, 24/7 telemedicine, and personalized insurance navigation into one simple platform. Eden provides an experience that employees love and saves employers money with seamless, data-driven healthcare.
Cancer Nutrition Centers is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Perot Systems Corporation is a Plano, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.